S&P 500   5,137.13 (+0.80%)
DOW   39,077.86 (+0.21%)
QQQ   445.92 (+1.58%)
AAPL   179.80 (-0.53%)
MSFT   414.74 (+0.27%)
META   501.85 (+2.39%)
GOOGL   138.13 (-0.24%)
AMZN   178.43 (+0.94%)
TSLA   202.93 (+0.52%)
NVDA   821.00 (+3.78%)
NIO   5.82 (+1.22%)
AMD   201.60 (+4.71%)
BABA   74.71 (+0.92%)
T   16.98 (+0.30%)
F   12.42 (-0.16%)
MU   95.72 (+5.64%)
CGC   3.21 (-2.43%)
GE   159.02 (+1.36%)
DIS   111.85 (+0.24%)
AMC   4.39 (+1.62%)
PFE   26.61 (+0.19%)
PYPL   60.66 (+0.53%)
XOM   105.75 (+1.18%)
S&P 500   5,137.13 (+0.80%)
DOW   39,077.86 (+0.21%)
QQQ   445.92 (+1.58%)
AAPL   179.80 (-0.53%)
MSFT   414.74 (+0.27%)
META   501.85 (+2.39%)
GOOGL   138.13 (-0.24%)
AMZN   178.43 (+0.94%)
TSLA   202.93 (+0.52%)
NVDA   821.00 (+3.78%)
NIO   5.82 (+1.22%)
AMD   201.60 (+4.71%)
BABA   74.71 (+0.92%)
T   16.98 (+0.30%)
F   12.42 (-0.16%)
MU   95.72 (+5.64%)
CGC   3.21 (-2.43%)
GE   159.02 (+1.36%)
DIS   111.85 (+0.24%)
AMC   4.39 (+1.62%)
PFE   26.61 (+0.19%)
PYPL   60.66 (+0.53%)
XOM   105.75 (+1.18%)
S&P 500   5,137.13 (+0.80%)
DOW   39,077.86 (+0.21%)
QQQ   445.92 (+1.58%)
AAPL   179.80 (-0.53%)
MSFT   414.74 (+0.27%)
META   501.85 (+2.39%)
GOOGL   138.13 (-0.24%)
AMZN   178.43 (+0.94%)
TSLA   202.93 (+0.52%)
NVDA   821.00 (+3.78%)
NIO   5.82 (+1.22%)
AMD   201.60 (+4.71%)
BABA   74.71 (+0.92%)
T   16.98 (+0.30%)
F   12.42 (-0.16%)
MU   95.72 (+5.64%)
CGC   3.21 (-2.43%)
GE   159.02 (+1.36%)
DIS   111.85 (+0.24%)
AMC   4.39 (+1.62%)
PFE   26.61 (+0.19%)
PYPL   60.66 (+0.53%)
XOM   105.75 (+1.18%)
S&P 500   5,137.13 (+0.80%)
DOW   39,077.86 (+0.21%)
QQQ   445.92 (+1.58%)
AAPL   179.80 (-0.53%)
MSFT   414.74 (+0.27%)
META   501.85 (+2.39%)
GOOGL   138.13 (-0.24%)
AMZN   178.43 (+0.94%)
TSLA   202.93 (+0.52%)
NVDA   821.00 (+3.78%)
NIO   5.82 (+1.22%)
AMD   201.60 (+4.71%)
BABA   74.71 (+0.92%)
T   16.98 (+0.30%)
F   12.42 (-0.16%)
MU   95.72 (+5.64%)
CGC   3.21 (-2.43%)
GE   159.02 (+1.36%)
DIS   111.85 (+0.24%)
AMC   4.39 (+1.62%)
PFE   26.61 (+0.19%)
PYPL   60.66 (+0.53%)
XOM   105.75 (+1.18%)
NASDAQ:OMIC

Singular Genomics Systems (OMIC) Stock Price, News & Analysis

$0.61
+0.04 (+6.56%)
(As of 02:38 PM ET)
Today's Range
$0.56
$0.62
50-Day Range
$0.41
$0.61
52-Week Range
$0.31
$2.27
Volume
56,005 shs
Average Volume
124,950 shs
Market Capitalization
$44.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$0.85

Singular Genomics Systems MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
42.8% Upside
$0.85 Price Target
Short Interest
Healthy
1.95% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.94mentions of Singular Genomics Systems in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.64 out of 5 stars

Medical Sector

519th out of 957 stocks

Analytical Instruments Industry

17th out of 28 stocks


OMIC stock logo

About Singular Genomics Systems Stock (NASDAQ:OMIC)

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables for applications comprising single cell gene expression and proteomics, in situ RNA sequencing, and spatial RNA and proteomics applications for tissue. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California.

OMIC Stock Price History

OMIC Stock News Headlines

Singular Genomics Systems Inc.
Americans Now Favor Gold Over Stocks as an Investment Vehicle
Americans now consider gold a better long-term investment than stocks for the first time since 2013. But physical gold requires storage and insurance, and gold mining stocks come with significant risks. Fortunately, investors have found a little-known way to benefit from gold that avoids many of these challenges.
Singular Genomics Systems Founder Acquires 4.6% More Stock
Revolutionary Device Redefines Cancer Detection
Discover the breakthrough device that could transform the lives of the estimated 68 million Americans affected by skin cancer. Achieving unprecedented accuracy, this device identifies cancer's molecular signature in just 1.5 seconds. This innovation marks a rapid advance in the battle against cancer. See how investors are unlocking 10% in bonus shares for a limited time.
Recap: Singular Genomics Sys Q3 Earnings
OMIC Singular Genomics Systems, Inc.
Singular Genomics Systems Inc OMIC
Beware! 3 Biotech Stocks Waving Massive Red Flags Right Now
Q1 2023 Singular Genomics Systems Inc Earnings Call
See More Headlines
Receive OMIC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Singular Genomics Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/09/2021
Today
3/01/2024
Next Earnings (Estimated)
3/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Analytical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:OMIC
Fax
N/A
Employees
284
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$0.85
High Stock Price Target
$0.85
Low Stock Price Target
$0.85
Potential Upside/Downside
+49.1%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$-90,880,000.00
Net Margins
-3,571.18%
Pretax Margin
-3,571.18%

Debt

Sales & Book Value

Annual Sales
$760,000.00
Book Value
$3.65 per share

Miscellaneous

Free Float
57,314,000
Market Cap
$41.83 million
Optionable
Optionable
Beta
1.32
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for March 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Andrew Spaventa (Age 39)
    Founder, CEO, President & Chairperson of the Board
    Comp: $685.93k
  • Dr. David L. Barker Ph.D. (Age 82)
    Founder, Member of Scientific Advisory Board & Independent Director
    Comp: $63.75k
  • Dr. Eli N. Glezer Ph.D. (Age 55)
    Founder, Chief Scientific Officer & Chair of Scientific Advisory Board
    Comp: $496.5k
  • Mr. Dalen Meeter (Age 46)
    Chief Financial Officer
    Comp: $434.39k
  • Jyotsna Ghai
    Chief Operating Officer
  • Mr. Jorge Velarde Jr. (Age 57)
    MBA, Senior Vice President of Corporate Development & Strategy
  • Mr. Jeff Bullard
    Head of Sales
  • Mr. Vincent Brancaccio (Age 41)
    Head of Human Resources
  • Mr. Samuel Ropp Ph.D. (Age 50)
    Chief Commercial Officer














OMIC Stock Analysis - Frequently Asked Questions

Should I buy or sell Singular Genomics Systems stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Singular Genomics Systems in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" OMIC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OMIC, but not buy additional shares or sell existing shares.
View OMIC analyst ratings
or view top-rated stocks.

What is Singular Genomics Systems' stock price target for 2024?

1 analysts have issued twelve-month price targets for Singular Genomics Systems' stock. Their OMIC share price targets range from $0.85 to $0.85. On average, they anticipate the company's share price to reach $0.85 in the next twelve months. This suggests a possible upside of 42.8% from the stock's current price.
View analysts price targets for OMIC
or view top-rated stocks among Wall Street analysts.

How have OMIC shares performed in 2024?

Singular Genomics Systems' stock was trading at $0.4601 on January 1st, 2024. Since then, OMIC shares have increased by 29.3% and is now trading at $0.5951.
View the best growth stocks for 2024 here
.

When is Singular Genomics Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 7th 2024.
View our OMIC earnings forecast
.

How were Singular Genomics Systems' earnings last quarter?

Singular Genomics Systems, Inc. (NASDAQ:OMIC) announced its quarterly earnings results on Tuesday, November, 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.24) by $0.01. Singular Genomics Systems had a negative net margin of 3,571.18% and a negative trailing twelve-month return on equity of 40.38%.

What guidance has Singular Genomics Systems issued on next quarter's earnings?

Singular Genomics Systems issued an update on its fourth quarter 2023 earnings guidance on Monday, January, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.0 million-$1.0 million, compared to the consensus revenue estimate of 590000.000.

When did Singular Genomics Systems IPO?

(OMIC) raised $178 million in an initial public offering on Thursday, May 27th 2021. The company issued 8,500,000 shares at $20.00-$22.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Cowen and UBS Investment Bank served as the underwriters for the IPO.

Who are Singular Genomics Systems' major shareholders?

Singular Genomics Systems' stock is owned by many different institutional and retail investors. Top institutional investors include Perceptive Advisors LLC (2.90%), Vanguard Group Inc. (2.55%), Weil Company Inc. (0.19%), Bridgeway Capital Management LLC (0.17%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Andrew Spaventa, Eli N Glezer, James E Flynn, Kim P Kamdar, Michael J Pellini and Sheryl L Conley.
View institutional ownership trends
.

How do I buy shares of Singular Genomics Systems?

Shares of OMIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:OMIC) was last updated on 3/1/2024 by MarketBeat.com Staff